esario, Author at Next Biomics

Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury in mice

Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury in mice

esario2024-04-23T14:36:41+00:00April 23rd, 2024|

Authors: Giovanni Sarnelli, Alessandro Del Rec, Irene Palencac, Silvia Basili Franzinc, Jie Lub, Luisa Seguella, Aurora Zilli, Marcella Pesce, Sara Rurgo, Giovanni Esposito, Walter Sanseverino, Giuseppe Esposito. Publication: Biomedicine & Pharmacotherapy While current anti-Spike protein (SP) vaccines have been pivotal in managing the pandemic, their limitations in delivery, storage, and the inability to provide mucosal [...]

Intranasal delivery of PEA-producing Lactobacillus paracasei F19 alleviates SARS-CoV-2 spike protein-induced lung injury in mice

Intranasal delivery of PEA-producing Lactobacillus paracasei F19 alleviates SARS-CoV-2 spike protein-induced lung injury in mice

esario2024-04-10T09:32:56+00:00April 10th, 2024|

Authors: Alessandro Del Re, Silvia Basili Franzin, Jie Lu, Irene Palenca, Aurora Zilli, Federico Pepi, Anna Troiani, Luisa Seguella, Marcella Pesce, Giovanni Esposito, Giovanni Sarnelli & Giuseppe Esposito Publication: Translational Medicine Communications - Published: 20 March 2024 - Volume 9, article number 9, (2024)

Oral Immunization with Escherichia coli Nissle 1917 Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice

Oral Immunization with Escherichia coli Nissle 1917 Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice

esario2024-04-19T10:44:51+00:00February 10th, 2024|

Authors: Giovanni Sarnelli, Alessandro Del Re, Marcella Pesce, Jie Lu, Giovanni Esposito, Walter Sanseverino, Chiara Corpetti, Silvia Basili Franzin, Luisa Seguella, Irene Palenca, Sara Rurgo, Fatima Domenica, Elisa De Palma, Aurora Zilli and Giuseppe Esposito. Publication: Biomolecules - Submission received: 15 January 2023 / Revised: 4 March 2023 / Accepted: 14 March 2023 / Published: [...]

Phytotherapics in COVID19: Why palmitoylethanolamide?

Phytotherapics in COVID19: Why palmitoylethanolamide?

esario2023-02-08T12:08:01+00:00February 8th, 2023|

Authors: Pesce M, Seguella L, Cassarano S, Aurino L, Sanseverino W, Lu J, Corpetti C, Del Re A, Vincenzi M, Sarnelli G, Esposito G. Publication: Phytother Res. 2020 Dec 9. doi: 10.1002/ptr.6978. Epub ahead of print. PMID: 33296131.

Next-Generation Probiotics for Inflammatory Bowel Disease

Next-Generation Probiotics for Inflammatory Bowel Disease

esario2024-04-10T09:39:44+00:00February 4th, 2023|

Authors: Pesce M, Seguella L, Del Re A, Lu J, Palenca I, Corpetti C, Rurgo S, Sanseverino W, Sarnelli G, Esposito G. Publication: Int J Mol Sci. 2022 May 13;23(10):5466. doi: 10.3390/ijms23105466. PMID: 35628274; PMCID: PMC9141965.prevention.

A palmitoylethanolamide producing Lactobacillus paracasei improves Clostridium difficile Toxin A-induced colitis.

A palmitoylethanolamide producing Lactobacillus paracasei improves Clostridium difficile Toxin A-induced colitis.

esario2024-04-10T09:39:50+00:00May 7th, 2021|

Authors: Esposito G, Corpetti C, Pesce M, Seguella L, Del Re A, Vincenzi M, Lattanzi R, Lu J, Sanseverino W, Sarnelli G. Institutions: Department of Physiology and Pharmacology, “V. Erspamer”, Sapienza University of Rome, Rome, Italy Nextbiomics S.r.l., Naples, Italy Department of Clinical Medicine and Surgery, Section of Gastroenterology, University Federico II, Naples, Italy Department [...]